Loading…

TNF GENE EXPRESSION IN MONOCYTES OF LOW AND HIGH RESPONDER INDIVIDUALS

Individuals with a consistently lower immune response may be more susceptible to infection but less prone to autoimmune disease or severe sepsis. The molecular mechanisms determining the low responder status are, however, unclear. We have screened 60 male donors for tumour necrosis factor (TNF) prot...

Full description

Saved in:
Bibliographic Details
Published in:Cytokine (Philadelphia, Pa.) Pa.), 1997-03, Vol.9 (3), p.206-211
Main Authors: Schraut, Winfried, Wendelgass, Petra, Calzada-Wack, Julia C., Frankenberger, Marion, Ziegler-Heitbrock, H.W.Löms
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c339t-6a29a7a9d756884890bad30474efab9228a25d61fcbb17262ccf85200ecd1ea03
cites
container_end_page 211
container_issue 3
container_start_page 206
container_title Cytokine (Philadelphia, Pa.)
container_volume 9
creator Schraut, Winfried
Wendelgass, Petra
Calzada-Wack, Julia C.
Frankenberger, Marion
Ziegler-Heitbrock, H.W.Löms
description Individuals with a consistently lower immune response may be more susceptible to infection but less prone to autoimmune disease or severe sepsis. The molecular mechanisms determining the low responder status are, however, unclear. We have screened 60 male donors for tumour necrosis factor (TNF) protein levels after stimulation of monocytes with lipopolysaccharide (LPS). Among these we identified three donors each that consistently had a level of less than 20% (low responders; LR) or of more than 80% (high responders; HR) of the maximum response seen in this population. Northern blot analysis of TNF mRNA after LPS stimulation revealed lower transcript levels in LR. Half life determination after actinomycin D blockade showed a similar decay rate for LR and HR and after blockade of degradation by cycloheximide treatment mRNA levels increased but LR remained lower compared to HR. These data indicate that the lower TNF mRNA levels in LR are not due to a more rapid mRNA degradation but rather a result of lower transcription. Transcripts for interleukin 6 (IL-6) were also low in LPS-stimulated monocytes of LR. Because expression of the LPS receptor CD14 was similar in LR and HR monocytes, our data suggest that differences in signal transduction account for the LR and HR phenotype.
doi_str_mv 10.1006/cyto.1996.0155
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78996111</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043466696901556</els_id><sourcerecordid>78996111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-6a29a7a9d756884890bad30474efab9228a25d61fcbb17262ccf85200ecd1ea03</originalsourceid><addsrcrecordid>eNp1kD1rwzAQhkVpSdO0a7eCpm52T7ItWWNI7MSQ2iEf_ZiELMvgksSplRTy72uT0K3THbzPvXAPQo8EXALAXvTpULtECOYCCYIr1CcgmANAvetu9z3HZ4zdojtrvwBAeJz3UE8QyjiIPopXaYwnURrh6GO-iJbLJEtxkuLXLM1Gn6toibMYz7J3PEzHeJpMpriF5lk6jhYtNk7ekvF6OFveo5tSbax5uMwBWsfRajR1ZtkkGQ1njvY8cXCYokJxJQoesDD0QwG5KjzwuW9KlQtKQ0WDgpFS5znhlFGtyzCgAEYXxCjwBuj53Ltv6u-jsQe5raw2m43amfpoJQ9bE4SQFnTPoG5qaxtTyn1TbVVzkgRkJ0524mQnTnbi2oOnS_Mx35riD7-YavPwnJv2vZ_KNNLqyuy0KarG6IMs6uq_6l-BYXXc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78996111</pqid></control><display><type>article</type><title>TNF GENE EXPRESSION IN MONOCYTES OF LOW AND HIGH RESPONDER INDIVIDUALS</title><source>ScienceDirect Freedom Collection</source><creator>Schraut, Winfried ; Wendelgass, Petra ; Calzada-Wack, Julia C. ; Frankenberger, Marion ; Ziegler-Heitbrock, H.W.Löms</creator><creatorcontrib>Schraut, Winfried ; Wendelgass, Petra ; Calzada-Wack, Julia C. ; Frankenberger, Marion ; Ziegler-Heitbrock, H.W.Löms</creatorcontrib><description>Individuals with a consistently lower immune response may be more susceptible to infection but less prone to autoimmune disease or severe sepsis. The molecular mechanisms determining the low responder status are, however, unclear. We have screened 60 male donors for tumour necrosis factor (TNF) protein levels after stimulation of monocytes with lipopolysaccharide (LPS). Among these we identified three donors each that consistently had a level of less than 20% (low responders; LR) or of more than 80% (high responders; HR) of the maximum response seen in this population. Northern blot analysis of TNF mRNA after LPS stimulation revealed lower transcript levels in LR. Half life determination after actinomycin D blockade showed a similar decay rate for LR and HR and after blockade of degradation by cycloheximide treatment mRNA levels increased but LR remained lower compared to HR. These data indicate that the lower TNF mRNA levels in LR are not due to a more rapid mRNA degradation but rather a result of lower transcription. Transcripts for interleukin 6 (IL-6) were also low in LPS-stimulated monocytes of LR. Because expression of the LPS receptor CD14 was similar in LR and HR monocytes, our data suggest that differences in signal transduction account for the LR and HR phenotype.</description><identifier>ISSN: 1043-4666</identifier><identifier>EISSN: 1096-0023</identifier><identifier>DOI: 10.1006/cyto.1996.0155</identifier><identifier>PMID: 9126709</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Blotting, Northern ; Cycloheximide - pharmacology ; Dactinomycin - pharmacology ; Enzyme-Linked Immunosorbent Assay ; Gene Expression Regulation ; Humans ; Immunity ; Interleukin-6 - genetics ; Interleukin-6 - metabolism ; Lipopolysaccharides - pharmacology ; LPS ; Male ; Monocyte ; Monocytes - drug effects ; Monocytes - metabolism ; Nucleic Acid Synthesis Inhibitors - pharmacology ; Protein Synthesis Inhibitors - pharmacology ; RNA, Messenger - metabolism ; Signal Transduction ; TNF ; Tumor Necrosis Factor-alpha - biosynthesis ; Tumor Necrosis Factor-alpha - genetics</subject><ispartof>Cytokine (Philadelphia, Pa.), 1997-03, Vol.9 (3), p.206-211</ispartof><rights>1997 Academic Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-6a29a7a9d756884890bad30474efab9228a25d61fcbb17262ccf85200ecd1ea03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9126709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schraut, Winfried</creatorcontrib><creatorcontrib>Wendelgass, Petra</creatorcontrib><creatorcontrib>Calzada-Wack, Julia C.</creatorcontrib><creatorcontrib>Frankenberger, Marion</creatorcontrib><creatorcontrib>Ziegler-Heitbrock, H.W.Löms</creatorcontrib><title>TNF GENE EXPRESSION IN MONOCYTES OF LOW AND HIGH RESPONDER INDIVIDUALS</title><title>Cytokine (Philadelphia, Pa.)</title><addtitle>Cytokine</addtitle><description>Individuals with a consistently lower immune response may be more susceptible to infection but less prone to autoimmune disease or severe sepsis. The molecular mechanisms determining the low responder status are, however, unclear. We have screened 60 male donors for tumour necrosis factor (TNF) protein levels after stimulation of monocytes with lipopolysaccharide (LPS). Among these we identified three donors each that consistently had a level of less than 20% (low responders; LR) or of more than 80% (high responders; HR) of the maximum response seen in this population. Northern blot analysis of TNF mRNA after LPS stimulation revealed lower transcript levels in LR. Half life determination after actinomycin D blockade showed a similar decay rate for LR and HR and after blockade of degradation by cycloheximide treatment mRNA levels increased but LR remained lower compared to HR. These data indicate that the lower TNF mRNA levels in LR are not due to a more rapid mRNA degradation but rather a result of lower transcription. Transcripts for interleukin 6 (IL-6) were also low in LPS-stimulated monocytes of LR. Because expression of the LPS receptor CD14 was similar in LR and HR monocytes, our data suggest that differences in signal transduction account for the LR and HR phenotype.</description><subject>Blotting, Northern</subject><subject>Cycloheximide - pharmacology</subject><subject>Dactinomycin - pharmacology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Gene Expression Regulation</subject><subject>Humans</subject><subject>Immunity</subject><subject>Interleukin-6 - genetics</subject><subject>Interleukin-6 - metabolism</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>LPS</subject><subject>Male</subject><subject>Monocyte</subject><subject>Monocytes - drug effects</subject><subject>Monocytes - metabolism</subject><subject>Nucleic Acid Synthesis Inhibitors - pharmacology</subject><subject>Protein Synthesis Inhibitors - pharmacology</subject><subject>RNA, Messenger - metabolism</subject><subject>Signal Transduction</subject><subject>TNF</subject><subject>Tumor Necrosis Factor-alpha - biosynthesis</subject><subject>Tumor Necrosis Factor-alpha - genetics</subject><issn>1043-4666</issn><issn>1096-0023</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNp1kD1rwzAQhkVpSdO0a7eCpm52T7ItWWNI7MSQ2iEf_ZiELMvgksSplRTy72uT0K3THbzPvXAPQo8EXALAXvTpULtECOYCCYIr1CcgmANAvetu9z3HZ4zdojtrvwBAeJz3UE8QyjiIPopXaYwnURrh6GO-iJbLJEtxkuLXLM1Gn6toibMYz7J3PEzHeJpMpriF5lk6jhYtNk7ekvF6OFveo5tSbax5uMwBWsfRajR1ZtkkGQ1njvY8cXCYokJxJQoesDD0QwG5KjzwuW9KlQtKQ0WDgpFS5znhlFGtyzCgAEYXxCjwBuj53Ltv6u-jsQe5raw2m43amfpoJQ9bE4SQFnTPoG5qaxtTyn1TbVVzkgRkJ0524mQnTnbi2oOnS_Mx35riD7-YavPwnJv2vZ_KNNLqyuy0KarG6IMs6uq_6l-BYXXc</recordid><startdate>19970301</startdate><enddate>19970301</enddate><creator>Schraut, Winfried</creator><creator>Wendelgass, Petra</creator><creator>Calzada-Wack, Julia C.</creator><creator>Frankenberger, Marion</creator><creator>Ziegler-Heitbrock, H.W.Löms</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19970301</creationdate><title>TNF GENE EXPRESSION IN MONOCYTES OF LOW AND HIGH RESPONDER INDIVIDUALS</title><author>Schraut, Winfried ; Wendelgass, Petra ; Calzada-Wack, Julia C. ; Frankenberger, Marion ; Ziegler-Heitbrock, H.W.Löms</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-6a29a7a9d756884890bad30474efab9228a25d61fcbb17262ccf85200ecd1ea03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Blotting, Northern</topic><topic>Cycloheximide - pharmacology</topic><topic>Dactinomycin - pharmacology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Gene Expression Regulation</topic><topic>Humans</topic><topic>Immunity</topic><topic>Interleukin-6 - genetics</topic><topic>Interleukin-6 - metabolism</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>LPS</topic><topic>Male</topic><topic>Monocyte</topic><topic>Monocytes - drug effects</topic><topic>Monocytes - metabolism</topic><topic>Nucleic Acid Synthesis Inhibitors - pharmacology</topic><topic>Protein Synthesis Inhibitors - pharmacology</topic><topic>RNA, Messenger - metabolism</topic><topic>Signal Transduction</topic><topic>TNF</topic><topic>Tumor Necrosis Factor-alpha - biosynthesis</topic><topic>Tumor Necrosis Factor-alpha - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schraut, Winfried</creatorcontrib><creatorcontrib>Wendelgass, Petra</creatorcontrib><creatorcontrib>Calzada-Wack, Julia C.</creatorcontrib><creatorcontrib>Frankenberger, Marion</creatorcontrib><creatorcontrib>Ziegler-Heitbrock, H.W.Löms</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cytokine (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schraut, Winfried</au><au>Wendelgass, Petra</au><au>Calzada-Wack, Julia C.</au><au>Frankenberger, Marion</au><au>Ziegler-Heitbrock, H.W.Löms</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TNF GENE EXPRESSION IN MONOCYTES OF LOW AND HIGH RESPONDER INDIVIDUALS</atitle><jtitle>Cytokine (Philadelphia, Pa.)</jtitle><addtitle>Cytokine</addtitle><date>1997-03-01</date><risdate>1997</risdate><volume>9</volume><issue>3</issue><spage>206</spage><epage>211</epage><pages>206-211</pages><issn>1043-4666</issn><eissn>1096-0023</eissn><abstract>Individuals with a consistently lower immune response may be more susceptible to infection but less prone to autoimmune disease or severe sepsis. The molecular mechanisms determining the low responder status are, however, unclear. We have screened 60 male donors for tumour necrosis factor (TNF) protein levels after stimulation of monocytes with lipopolysaccharide (LPS). Among these we identified three donors each that consistently had a level of less than 20% (low responders; LR) or of more than 80% (high responders; HR) of the maximum response seen in this population. Northern blot analysis of TNF mRNA after LPS stimulation revealed lower transcript levels in LR. Half life determination after actinomycin D blockade showed a similar decay rate for LR and HR and after blockade of degradation by cycloheximide treatment mRNA levels increased but LR remained lower compared to HR. These data indicate that the lower TNF mRNA levels in LR are not due to a more rapid mRNA degradation but rather a result of lower transcription. Transcripts for interleukin 6 (IL-6) were also low in LPS-stimulated monocytes of LR. Because expression of the LPS receptor CD14 was similar in LR and HR monocytes, our data suggest that differences in signal transduction account for the LR and HR phenotype.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>9126709</pmid><doi>10.1006/cyto.1996.0155</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1043-4666
ispartof Cytokine (Philadelphia, Pa.), 1997-03, Vol.9 (3), p.206-211
issn 1043-4666
1096-0023
language eng
recordid cdi_proquest_miscellaneous_78996111
source ScienceDirect Freedom Collection
subjects Blotting, Northern
Cycloheximide - pharmacology
Dactinomycin - pharmacology
Enzyme-Linked Immunosorbent Assay
Gene Expression Regulation
Humans
Immunity
Interleukin-6 - genetics
Interleukin-6 - metabolism
Lipopolysaccharides - pharmacology
LPS
Male
Monocyte
Monocytes - drug effects
Monocytes - metabolism
Nucleic Acid Synthesis Inhibitors - pharmacology
Protein Synthesis Inhibitors - pharmacology
RNA, Messenger - metabolism
Signal Transduction
TNF
Tumor Necrosis Factor-alpha - biosynthesis
Tumor Necrosis Factor-alpha - genetics
title TNF GENE EXPRESSION IN MONOCYTES OF LOW AND HIGH RESPONDER INDIVIDUALS
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A07%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TNF%20GENE%20EXPRESSION%20IN%20MONOCYTES%20OF%20LOW%20AND%20HIGH%20RESPONDER%20INDIVIDUALS&rft.jtitle=Cytokine%20(Philadelphia,%20Pa.)&rft.au=Schraut,%20Winfried&rft.date=1997-03-01&rft.volume=9&rft.issue=3&rft.spage=206&rft.epage=211&rft.pages=206-211&rft.issn=1043-4666&rft.eissn=1096-0023&rft_id=info:doi/10.1006/cyto.1996.0155&rft_dat=%3Cproquest_cross%3E78996111%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c339t-6a29a7a9d756884890bad30474efab9228a25d61fcbb17262ccf85200ecd1ea03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78996111&rft_id=info:pmid/9126709&rfr_iscdi=true